Gene Therapy May Be Effective In Treating Diabetes

Gene Therapy May Be Effective In Treating DiabetesBoffins from Baylor College of Medicine in Houston have formulated an experimental cure for Type 1 diabetes.

By making use of gene therapy, the research group tried to counter the two defects, which result in Type 1 diabetes: autoimmune attack and destruction of the insulin-producing beta cells.

They utilized non-obese diabetic mice that spontaneously develop diabetes owing to autoimmunity, just as humans do with Type 1 diabetes.

Study co-author Lawrence Chan, chief of Baylor''s diabetes, endocrinology and metabolism division said, "A single treatment cured about 50 percent of the diabetic mice, restoring their blood sugar to normal so that they no longer need insulin injections."

Type 1 diabetes takes place when the immune system of the human body attacks and annihilates the beta cells in the pancreas, the insulin "factory" of the body.

The resulting near-complete deficiency of insulin-the hormone, which controls the levels of blood sugar results in a buildup of high blood sugar and thus diabetes.

In this study, Chan stated that they "added to the original gene therapy approach a protective gene that shields the newly formed beta cells from autoimmune attack."

Earlier researches showed that interleukin-10 can stop diabetes development in mice but cannot reverse the illness once it has developed due to the lack of beta cells.

But, when the scientists combined the gene therapy with interleukin-10 into a single intravenous injection, the treatment showed a complete reversal of diabetes in half of the mice during more than 20 months'' follow-up.

Although the therapy did not reverse autoimmunity throughout the body, it protected the new beta cells from the local destructive effect of autoimmunity, Chan explained.

The results of the research have been released suring The Endocrine Society''s 92nd Annual Meeting in San Diego. (With Inputs from Agencies)